Amyloid imaging in cognitively normal individuals, at-risk populations and preclinical Alzheimer's disease

被引:271
作者
Chetelat, Gael [1 ,2 ,3 ,4 ]
La Joie, Renaud [1 ,2 ,3 ,4 ]
Villain, Nicolas [1 ,2 ,3 ,4 ]
Perrotin, Audrey [1 ,2 ,3 ,4 ]
de La Sayette, Vincent [1 ,2 ,3 ,4 ,5 ]
Eustache, Francis [1 ,2 ,3 ,4 ]
Vandenberghe, Rik [6 ,7 ,8 ]
机构
[1] INSERM, U1077, Caen, France
[2] Univ Caen Basse Normandie, UMR S1077, Caen, France
[3] Ecole Prat Hautes Etud, UMR S1077, Caen, France
[4] CHU Caen, U1077, F-14000 Caen, France
[5] CHU Caen, Serv Neurol, F-14000 Caen, France
[6] Univ Leuven, Dept Neurosci, Lab Cognit Neurol, Leuven, Belgium
[7] Univ Hosp Leuven, Dept Neurol, Leuven, Belgium
[8] Univ Leuven, KU Leuven, Alzheimer Res Ctr, Leuven Inst Neurosci & Dis, Leuven, Belgium
关键词
Amyloid PET imaging; Cognitively normal elderly; Preclinical Alzheimer's disease; Subjective cognitive decline; ApoE4; Longitudinal studies; POSITRON-EMISSION-TOMOGRAPHY; FLORBETAPIR F 18; BETA-PEPTIDE DEPOSITION; NORMAL OLDER-ADULTS; ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; MEMORY PERFORMANCE; FAMILY-HISTORY; GENETIC RISK;
D O I
10.1016/j.nicl.2013.02.006
中图分类号
R445 [影像诊断学];
学科分类号
100207 ;
摘要
Recent developments of PET amyloid ligands have made it possible to visualize the presence of A beta deposition in the brain of living participants and to assess the consequences especially in individuals with no objective sign of cognitive deficits. The present review will focus on amyloid imaging in cognitively normal elderly, asymptomatic at-risk populations, and individuals with subjective cognitive decline. It will cover the prevalence of amyloid-positive cases amongst cognitively normal elderly, the influence of risk factors for AD, the relationships to cognition, atrophy and prognosis, longitudinal amyloid imaging and ethical aspects related to amyloid imaging in cognitively normal individuals. Almost ten years of research have led to a few consensual and relatively consistent findings: some cognitively normal elderly have A beta deposition in their brain, the prevalence of amyloid-positive cases increases in at-risk populations, the prognosis for these individuals is worse than for those with no A beta deposition, and significant increase in A beta deposition over time is detectable in cognitively normal elderly. More inconsistent findings are still under debate; these include the relationship between A beta deposition and cognition and brain volume, the sequence and cause-to-effect relations between the different AD biomarkers, and the individual outcome associated with an amyloid positive versus negative scan. Preclinical amyloid imaging also raises important ethical issues. While amyloid imaging is definitely useful to understand the role of A beta in early stages, to define at-risk populations for research or for clinical trial, and to assess the effects of anti-amyloid treatments, we are not ready yet to translate research results into clinical practice and policy. More researches are needed to determine which information to disclose from an individual amyloid imaging scan, the way of disclosing such information and the impact on individuals and on society. (C) 2013 The Authors. Published by Elsevier Inc.
引用
收藏
页码:356 / 365
页数:10
相关论文
共 119 条
  • [111] Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study
    Villain, Nicolas
    Chetelat, Gael
    Grassiot, Blandine
    Bourgeat, Pierrick
    Jones, Gareth
    Ellis, Kathryn A.
    Ames, David
    Martins, Ralph N.
    Eustache, Francis
    Salvado, Olivier
    Masters, Colin L.
    Rowe, Christopher C.
    Villemagne, Victor L.
    [J]. BRAIN, 2012, 135 : 2126 - 2139
  • [112] Aβ Imaging: feasible, pertinent, and vital to progress in Alzheimer's disease
    Villemagne, Victor L.
    Klunk, William E.
    Mathis, Chester A.
    Rowe, Christopher C.
    Brooks, David J.
    Hyman, Bradley T.
    Ikonomovic, Milos D.
    Ishii, Kenji
    Jack, Clifford R.
    Jagust, William J.
    Johnson, Keith A.
    Koeppe, Robert A.
    Lowe, Val J.
    Masters, Colin L.
    Montine, Thomas J.
    Morris, John C.
    Nordberg, Agneta
    Petersen, Ronald C.
    Reiman, Eric M.
    Selkoe, Dennis J.
    Sperling, Reisa A.
    Van Laere, Koen
    Weiner, Michael W.
    Drzezga, Alexander
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 (02) : 209 - 219
  • [113] Longitudinal Assessment of Aβ and Cognition in Aging and Alzheimer Disease
    Villemagne, Victor L.
    Pike, Kerryn E.
    Chetelat, Gael
    Ellis, Kathryn A.
    Mulligan, Rachel S.
    Bourgeat, Pierrick
    Ackermann, Uwe
    Jones, Gareth
    Szoeke, Cassandra
    Salvado, Olivier
    Martins, Ralph
    O'Keefe, Graeme
    Mathis, Chester A.
    Klunk, William E.
    Ames, David
    Masters, Colin L.
    Rowe, Christopher C.
    [J]. ANNALS OF NEUROLOGY, 2011, 69 (01) : 181 - 192
  • [114] Villemagne VL, 2009, ARCH NEUROL-CHICAGO, V66, P1537, DOI 10.1001/archneurol.2009.285
  • [115] Amyloid-beta plaque growth in cognitively normal adults: Longitudinal [11C]Pittsburgh compound B data
    Vlassenko, Andrei G.
    Mintun, Mark A.
    Xiong, Chengjie
    Sheline, Yvette I.
    Goate, Alison M.
    Benzinger, Tammie L. S.
    Morris, John C.
    [J]. ANNALS OF NEUROLOGY, 2011, 70 (05) : 857 - 861
  • [116] The Alzheimer's Disease Neuroimaging Initiative: Progress report and future plans
    Weiner, Michael W.
    Aisen, Paul S.
    Jack, Clifford R., Jr.
    Jagust, William J.
    Trojanowski, John Q.
    Shaw, Leslie
    Saykin, Andrew J.
    Morris, John C.
    Cairns, Nigel
    Beckett, Laurel A.
    Toga, Arthur
    Green, Robert
    Walter, Sarah
    Soares, Holly
    Snyder, Peter
    Siemers, Eric
    Potter, William
    Cole, Patricia E.
    Schmidt, Mark
    [J]. ALZHEIMERS & DEMENTIA, 2010, 6 (03) : 202 - 211
  • [117] Comparison of Imaging Biomarkers in the Alzheimer Disease Neuroimaging Initiative and the Mayo Clinic Study of Aging
    Whitwell, Jennifer L.
    Wiste, Heather J.
    Weigand, Stephen D.
    Rocca, Walter A.
    Knopman, David S.
    Roberts, Rosebud O.
    Boeve, Bradley F.
    Petersen, Ronald C.
    Jack, Clifford R., Jr.
    [J]. ARCHIVES OF NEUROLOGY, 2012, 69 (05) : 614 - 622
  • [118] In Vivo Imaging of Amyloid Deposition in Alzheimer Disease Using the Radioligand 18F-AV-45 (Flobetapir F 18)
    Wong, Dean F.
    Rosenberg, Paul B.
    Zhou, Yun
    Kumar, Anil
    Raymont, Vanessa
    Ravert, Hayden T.
    Dannals, Robert F.
    Nandi, Ayon
    Brasic, James R.
    Ye, Weiguo
    Hilton, John
    Lyketsos, Constantine
    Kung, Hank F.
    Joshi, Abhinay D.
    Skovronsky, Daniel M.
    Pontecorvo, Michael J.
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2010, 51 (06) : 913 - 920
  • [119] Role of Family History for Alzheimer Biomarker Abnormalities in the Adult Children Study
    Xiong, Chengjie
    Roe, Catherine M.
    Buckles, Virginia
    Fagan, Anne
    Holtzman, David
    Balota, David
    Duchek, Janet
    Storandt, Martha
    Mintun, Mark
    Grant, Elizabeth
    Snyder, Abraham Z.
    Head, Denise
    Benzinger, Tammie L. S.
    Mettenburg, Joseph
    Csernansky, John
    Morris, John C.
    [J]. ARCHIVES OF NEUROLOGY, 2011, 68 (10) : 1313 - 1319